Literature DB >> 8476042

Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats.

H D McCarthy1, P E McKibbin, A V Perkins, E A Linton, G Williams.   

Abstract

Regional hypothalamic concentrations of neuropeptide Y (NPY) and corticotropin-releasing factor (CRF), respectively a stimulant and an inhibitor of feeding behavior, were investigated in hypothalamic nuclei in rats carrying the Yoshida sarcoma. Tumor-bearing rats (n = 10), non-tumor-bearing controls (n = 10), and food-restricted rats (n = 10), which did not carry tumors but were pair-fed to match the reduced food intake of the tumor-bearing group, were studied after 10 days. NPY concentrations in the arcuate nucleus (ARC, the main site of NPY synthesis) were significantly increased above controls (P < 0.01) in both tumor-bearing and food-restricted groups. However, NPY concentrations in the paraventricular nucleus (PVN, an NPY-sensitive site of NPY release) showed opposing changes, with a 25% decrease (P = 0.052) in the tumor-bearing but a 48% increase (P < 0.01) in the food-restricted group. CRF concentrations in both the PVN and the ARC were significantly reduced (P < 0.01) in the food-restricted group, but remained close to control values in the tumor-bearing group (P not significant). Changes in hypothalamic appetite-regulating neuropeptides in cancer anorexia, which may result from the action of cytokines produced by a host defense response or the tumor itself, may account for reduced feeding. Such changes may include impaired activity of NPY or failure of CRF activity to be suppressed after underfeeding and weight loss.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476042     DOI: 10.1152/ajpendo.1993.264.4.E638

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

Review 1.  Anorexia in cancer: role of feeding-regulatory peptides.

Authors:  Simona Perboni; Akio Inui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 2.  Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.

Authors:  Mitsuhiro Yoshimura; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2015-06-30       Impact factor: 2.781

3.  Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal.

Authors:  S C Heinrichs; J Lapsansky; D P Behan; R K Chan; P E Sawchenko; M Lorang; N Ling; W W Vale; E B De Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.

Authors:  P B Jensen; N Blume; J D Mikkelsen; P J Larsen; H I Jensen; J J Holst; O D Madsen
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 5.  Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.

Authors:  J Raber
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

6.  Characterization of the Yoshida sarcoma: a model of cancer cachexia.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Support Care Cancer       Date:  2013-05-21       Impact factor: 3.603

7.  Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Horm Cancer       Date:  2013-10-08       Impact factor: 3.869

8.  Neuropeptide Y and the development of cancer anorexia.

Authors:  W T Chance; A Balasubramaniam; J E Fischer
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

9.  Day-night pattern of energy expenditure and body temperature in cachectic tumour-bearing rats.

Authors:  H Oudart; A Malan; Y Maho; A Geloen
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

10.  Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling.

Authors:  Jvalini T Dwarkasing; Mark V Boekschoten; Joseph M Argilès; Miriam van Dijk; Silvia Busquets; Fabio Penna; Miriam Toledo; Alessandro Laviano; R F Witkamp; Klaske van Norren
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03-31       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.